Isobromindione
Chemical compound
- M04AB04 (WHO)
- 5-Bromo-2-phenyl-1H-indene-1,3(2H)-dione
- 1470-35-5
- 68953
- 62176
- J1J87P409K
- D07279
Y
- DTXSID90862674
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
- Interactive image
- c1ccc(cc1)C2C(=O)c3ccc(cc3C2=O)Br
InChI
- InChI=1S/C15H9BrO2/c16-10-6-7-11-12(8-10)15(18)13(14(11)17)9-4-2-1-3-5-9/h1-8,13H
- Key:QFLZIWVSQDZLNW-UHFFFAOYSA-N
Isobromindione is a drug used in the treatment of gout.[1][2]
References
- v
- t
- e
Drugs used for gout (M04)
primary |
|
---|---|
secondary |
purine analogues | |
---|---|
other |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e